114 related articles for article (PubMed ID: 23098809)
1. Antineutrophil cytoplasmic autoantibodies and clinical phenotype in patients with Churg-Strauss syndrome.
Sinico RA; Bottero P; Guillevin L
J Allergy Clin Immunol; 2012 Dec; 130(6):1440; author reply 1440-1. PubMed ID: 23098809
[No Abstract] [Full Text] [Related]
2. [Immunological tests: Anti-neutrophil cytoplasmic antibody].
Takizawa H
Nihon Rinsho; 2005 Jul; 63 Suppl 7():624-6. PubMed ID: 16111351
[No Abstract] [Full Text] [Related]
3. Getting rid of MPO-ANCA: a matter of disease subtype.
Bremer JP; Csernok E; Holle J; Gross WL; Moosig F
Rheumatology (Oxford); 2013 Apr; 52(4):752-4. PubMed ID: 23345506
[No Abstract] [Full Text] [Related]
4. [Anti-neutrophil cytoplasmic antibody(ANCA), MPO-ANCA, PR3-ANCA].
Takizawa H
Nihon Rinsho; 2010 Jun; 68 Suppl 6():694-6. PubMed ID: 20942166
[No Abstract] [Full Text] [Related]
5. The emergence of antineutrophil cytoplasmic antibodies may precede the clinical onset of Churg-Strauss syndrome.
Zwerina J; Axmann R; Manger B; Schett G
Arthritis Rheum; 2009 Feb; 60(2):626-7. PubMed ID: 19180487
[No Abstract] [Full Text] [Related]
6. Biotinylation of ANCA target antigen improves assay performance for PR3-ELISA but not MPO-ELISA.
Hayman MW; Slade CA; Spellerberg MB; O'Donnell JL
Pathology; 2013 Aug; 45(5):525-7. PubMed ID: 23842044
[No Abstract] [Full Text] [Related]
7. Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients.
Guillevin L; Visser H; Noel LH; Pourrat J; Vernier I; Gayraud M; Oksman F; Lesavre P
J Rheumatol; 1993 Aug; 20(8):1345-9. PubMed ID: 7901412
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome.
Healy B; Bibby S; Steele R; Weatherall M; Nelson H; Beasley R
J Allergy Clin Immunol; 2013 Feb; 131(2):571-6.e1-6. PubMed ID: 22920496
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.
Sinico RA; Di Toma L; Maggiore U; Bottero P; Radice A; Tosoni C; Grasselli C; Pavone L; Gregorini G; Monti S; Frassi M; Vecchio F; Corace C; Venegoni E; Buzio C
Arthritis Rheum; 2005 Sep; 52(9):2926-35. PubMed ID: 16142760
[TBL] [Abstract][Full Text] [Related]
10. Testing for antineutrophil cytoplasmic antibodies.
Zauli D; Grassi A; Ballardini G; Bianchi FB
Am J Clin Pathol; 2000 Mar; 113(3):455-6. PubMed ID: 10705826
[No Abstract] [Full Text] [Related]
11. L29. Relevance of anti-LAMP-2 in vasculitis: why the controversy.
Kain R
Presse Med; 2013 Apr; 42(4 Pt 2):584-8. PubMed ID: 23453500
[No Abstract] [Full Text] [Related]
12. [Antineutrophil cytoplasmic autoantibodies in systemic vasculitis].
Hagemo JS; Aasarød K; Moen T
Tidsskr Nor Laegeforen; 2002 May; 122(12):1185-8. PubMed ID: 12089844
[TBL] [Abstract][Full Text] [Related]
13. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
14. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis].
Nakano H; Ozaki S
Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457
[TBL] [Abstract][Full Text] [Related]
15. L27. Antibodies versus phenotypes: a clinician's view.
Jayne D
Presse Med; 2013 Apr; 42(4 Pt 2):579-82. PubMed ID: 23490640
[No Abstract] [Full Text] [Related]
16. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
Sinclair D; Stevens JM
Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
[TBL] [Abstract][Full Text] [Related]
17. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.
Schmitt WH; Csernok E; Kobayashi S; Klinkenborg A; Reinhold-Keller E; Gross WL
Arthritis Rheum; 1998 Mar; 41(3):445-52. PubMed ID: 9506572
[TBL] [Abstract][Full Text] [Related]
18. Crescentic glomerulonephritis and elevated antimyeloperoxidase antibody in a patient with Churg-Strauss syndrome.
Minami J; Ishibashi-Ueda H; Okano Y; Inenaga T; Nakanishi N; Kunieda T; Yutani C
Nephron; 1997; 77(1):105-8. PubMed ID: 9380224
[TBL] [Abstract][Full Text] [Related]
19. Churg-Strauss syndrome.
Pagnoux C; Guilpain P; Guillevin L
Curr Opin Rheumatol; 2007 Jan; 19(1):25-32. PubMed ID: 17143092
[TBL] [Abstract][Full Text] [Related]
20. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis.
Sinico RA; Radice A; Corace C; DI Toma L; Sabadini E
Ann N Y Acad Sci; 2005 Jun; 1050():185-92. PubMed ID: 16014533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
